Biopharma Competition Healthcare Provider Patients 
PM360
AUGUST 24, 2023
As professionals with more than a half-century between us working in biopharma and diagnostics marketing and communications from the corporate (Ayaz Malik) and agency (Sandra Stahl) sides, we believe nurturing multigenerational teams is an especially powerful yet underutilized strategy for our industry.
Impetus Digital
MARCH 15, 2024
In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. However, with rapid growth comes growing pains.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
APRIL 22, 2024
In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. ABIGAIL MALLON Chief Patient Experience Officer, VMS BioMarketing Physician burnout is on the rise. The second to increase in patient-oriented communication and support for physicians.
Clarivate
APRIL 18, 2024
While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare.
Clarivate
DECEMBER 6, 2022
In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.
Clarivate
APRIL 24, 2023
Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients. In January 2023, VillageMD acquired Summit Health for $8.9
PM360
AUGUST 9, 2022
Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Despite the rapid advances that have enabled these innovations, healthcare systems and commercial infrastructure aren’t keeping pace. In oncology, it’s 47% less.
Expert insights. Personalized for you.
98 
Let's personalize your content